Reducing the incidence and severity of herpes zoster and PHN with zoster vaccination

Journal of the American Osteopathic Association

Volumn 109, Issue 6 SUPPL. 2, 2009, Pages

  Gelb, Lawrence D ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; VARICELLA ZOSTER VACCINE;

CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFICACY; FOOD AND DRUG ADMINISTRATION; GERIATRIC CARE; GROUPS BY AGE; HEALTH PROGRAM; HERPES ZOSTER; HUMAN; INCIDENCE; MORTALITY; POSTHERPETIC NEURALGIA; UNITED STATES; VETERAN;

AGE FACTORS; AGED; HERPES ZOSTER; HERPES ZOSTER VACCINE; HUMANS; INCIDENCE; MIDDLE AGED;

EID: 67650496689     PISSN: 00986151     EISSN: 00986151     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (7)

1. Hope-Simpson RE. The nature of herpes zoster: a long-term study and a new hypothesis. Proc R Soc Med. 1965;58:9-20. Available at: http://www.pub medcentral.nih.gov/articlerender.fcgi?tool=pubme d&pubmedid=14267505. Accessed April 14, 2009.
2. Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, et al; Shingles Prevention Study Group. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med. 2005;352:2271-2284. Available at: http: //content.nejm.org/cgi/content/abstract/352/22 /2271. Accessed April 14, 2009.
3. Levin MJ, Murray M, Rotbart HA, Zerbe GO, White CJ, Hayward AR. Immune response of elderly individuals to a live attenuated varicella vaccine. J Infect Dis. 1992;166:253-259.
4. Levin MJ, Barber D, Goldblatt E, Jones M, LaFleur B, Chan C, et al. Use of a live attenuated varicella vaccine to boost varicella-specific immune responses in seropositive people 55 years of age and older: duration of booster effect. J Infect Dis. 1998;178(suppl 1):S109-S112. (Pubitemid 28514283)
5. Levin MJ, Smith JG, Kaufhold RM, Barber D, Hayward AR, Chan CY, et al. Decline in varicellazoster virus (VZV)-specific cell-mediated immunity with increasing age and boosting with a highdose VZV vaccine [published online ahead of print October 17, 2003]. J Infect Dis. 2003;188:1336- 1344. Available at: http://www.journals.uchicago .edu/doi/full /10.1086/379048. Accessed April 28, 2009. (Pubitemid 37433704)
6. Centers for Disease Control and Prevention. Shingles vaccine: what you need to know [vaccine information statement]. September 11, 2006. Available at: http://www.cdc.gov/vaccines/pubs /vis/downloads /vis-shingles.pdf. Accessed April 28, 2009.
7. Zostavax [package insert]. Whitehouse Station, NJ: Merck & Co Inc; 2007.